EYEPOINT PHARMACEUTICALS, INC.

Profile

Company Names

EYEPOINT PHARMACEUTICALS, INC.

Addresses

480 PLEASANT STREET, SUITE B300, WATERTOWN, MA 02472

Phone Numbers

617-926-5000

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$25,171,785.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2020-12-31 
$15,704,829.00 
$15,704,829.00 
$0.00 
Equity 
1
2018-03-28 
$9,466,956.00 
$35,000,000.00 
$25,533,044.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GORAN 
 
ANDO 
DIRECTOR
SWMF LIFE SCIENCE VENTURE FUND, LIMITED PARTNERSHIP   |  SELECTA BIOSCIENCES INC   |  EYEPOINT PHARMACEUTICALS, INC.
JAMES 
 
BARRY 
DIRECTOR
INSPIREMD, INC.   |  ARSENAL MEDICAL, INC.   |  EYEPOINT PHARMACEUTICALS, INC.   |  GRID7 LLC   |  U.S. REAL PROPERTY INCOME FUND, L.P.   |  EXCHANGE PLACE LP   |  REAL ESTATE VALUE ADD LP   |  EXCHANGE PLACE: ALL CAP LP   |  OFFALY GOOD FOODS, INC.   |  PHARMACANN INC.   |  CARDIAC IMPLANTS LLC   |  AGNOVOS BIOSCIENCE, INC.
WENDY 
 
DICICCO 
DIRECTOR
QUENCH USA, INC.   |  CANNAPHARMARX, INC.   |  CENTINEL SPINE, LLC   |  CARMELL THERAPEUTICS CORP   |  RENOVACOR, INC.   |  IMVAX, INC.   |  EYEPOINT PHARMACEUTICALS, INC.   |  EXPRESSCELLS, INC.   |  AKARI THERAPEUTICS PLC
JAY 
 
DUKER 
DIRECTOR
HEMERA BIOSCIENCES, INC.   |  EYEPOINT PHARMACEUTICALS, INC.
RONALD 
W. 
EASTMAN 
DIRECTOR
INTEGENX INC   |  EYEPOINT PHARMACEUTICALS, INC.
GEORGE 
O. 
ELSTON 
EXECUTIVE OFFICER
CELLDEX THERAPEUTICS, INC.   |  CELLDEX THERAPEUTICS, INC.   |  EYEPOINT PHARMACEUTICALS, INC.
DOUGLAS 
 
GODSHALL 
DIRECTOR
HEARTWARE INTERNATIONAL, INC.   |  NUPULSE INC.   |  VITAL THERAPIES INC   |  EYEPOINT PHARMACEUTICALS, INC.   |  SHOCKWAVE MEDICAL, INC.
DAVID 
R. 
GUYER, M.D. 
DIRECTOR
EYEPOINT PHARMACEUTICALS, INC.
SCOTT 
 
JONES 
EXECUTIVE OFFICER
MOG INC   |  TASEKO MINES LTD   |  POWERFILE INC   |  EXSULIN CORP   |  TUNESAT, LLC   |  BRAZOS SOFTWARE CORP   |  BRAND PASSPORT, INC.   |  NOESIS ENERGY, INC.   |  DESERT FOREST GOLF CLUB, INC.   |  TRISTREAM ENERGY, LLC   |  TRISTREAM CO-INVEST II LP   |  TRISTREAM CO-INVEST III LP   |  WHALE ROCK FLAGSHIP FUND LTD   |  ANANDAR EVENT OPPORTUNITIES MASTER FUND LTD.   |  RYDER COURT GLOBAL EMERGING MARKETS OPPORTUNITIES FUND (DST)   |  RYDER COURT US SMALL MID CAP EQUITY FUND (DST)   |  RYDER COURT EMERGING MARKETS SMALL CAP FUND (DST)   |  RYDER COURT EUROPEAN CONCENTRATED VALUE FUND (DST)   |  WHALE ROCK LONG OPPORTUNITIES FUND LTD   |  EYEPOINT PHARMACEUTICALS, INC.
JOHN 
 
LANDIS, PH.D., M.S. 
DIRECTOR
EYEPOINT PHARMACEUTICALS, INC.
YE 
 
LIU 
DIRECTOR
EYEPOINT PHARMACEUTICALS, INC.
NANCY 
 
LURKER 
EXECUTIVE OFFICER, DIRECTOR
X4 PHARMACEUTICALS, INC.   |  EYEPOINT PHARMACEUTICALS, INC.
DAVID 
 
MAZZO 
DIRECTOR
CALADRIUS BIOSCIENCES, INC.   |  EYEPOINT PHARMACEUTICALS, INC.   |  SENECA BIOPHARMA, INC.
DARIO 
 
PAGGIARINO 
EXECUTIVE OFFICER
EYEPOINT PHARMACEUTICALS, INC.
DARIO 
 
PAGGIARINO, M.D. 
EXECUTIVE OFFICER
EYEPOINT PHARMACEUTICALS, INC.
KRISTINE 
 
PETERSON 
DIRECTOR
VALERITAS INC   |  EYEPOINT PHARMACEUTICALS, INC.   |  IMMUNOCORE HOLDINGS PLC
MICHAEL 
 
ROGERS 
DIRECTOR
AGENT ALLIANCE REINSURANCE COMPANY, LTD.   |  THREEWIRE INC   |  SIRONA BIOCHEM CORP   |  R VALUE, INC.   |  MINDCHILD MEDICAL, INC   |  EYEPOINT PHARMACEUTICALS, INC.   |  APNIMED, INC.   |  MIRTLE MEDICAL LLC
LEONARD 
S. 
ROSS 
EXECUTIVE OFFICER
EYEPOINT PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-01-06
D
Link
PHARMACEUTICALS 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2020-12-31 
2018-04-12
D
Link
PHARMACEUTICALS 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2018-03-28 
2018-04-12
D
Link
PHARMACEUTICALS 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2018-03-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#